Article Details
Retrieved on: 2022-09-17 04:57:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
As a post-period event, On August 1, Innate disclosed that the INTERLINK-1 study Phase 3 sponsored by AstraZeneca's planned futility interim analysis ...
Article found on: www.bollyinside.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here